BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7105797)

  • 1. Secondary prevention of myocardial infarction in the elderly.
    Abrahamsen AM; Gundersen T; Rønnevik P
    Curr Med Res Opin; 1982; 7(Suppl 1):68-78. PubMed ID: 7105797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Timolol reduces mortality and reinfarct in patients surviving an acute myocardial infarct. The Norwegian Multicenter Study Group].
    MMW Munch Med Wochenschr; 1981 May; 123(22):929-38. PubMed ID: 6787417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter study on timolol in secondary prevention after myocardial infarction.
    Acta Med Scand Suppl; 1983; 674():1-129. PubMed ID: 6580807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Norwegian Multicenter Study of Timolol after Myocardial Infarction.
    Pedersen TR
    Circulation; 1983 Jun; 67(6 Pt 2):I49-53. PubMed ID: 6342838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Timolol Myocardial Infarction Study: an evaluation of selected variables.
    Rodda BE
    Circulation; 1983 Jun; 67(6 Pt 2):I101-6. PubMed ID: 6342836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-year follow-up of the Norwegian Multicenter Study on Timolol after Acute Myocardial Infarction.
    Pedersen TR
    N Engl J Med; 1985 Oct; 313(17):1055-8. PubMed ID: 2864634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timolol-related reduction in mortality and reinfarction in diabetic patients surviving acute myocardial infarction.
    Gundersen T; Kjekshus J
    Horm Metab Res Suppl; 1985; 15():58-60. PubMed ID: 3908282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Timolol prevention in acute myocardial infarct. A Norwegian multi-centre study].
    Andersen M
    Ugeskr Laeger; 1981; 143(34):2175-6. PubMed ID: 7025411
    [No Abstract]   [Full Text] [Related]  

  • 9. European Infarction Study (E.I.S.). A secondary prevention study with slow release oxprenolol after myocardial infarction: morbidity and mortality.
    Eur Heart J; 1984 Mar; 5(3):189-202. PubMed ID: 6373264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction.
    Norwegian Multicenter Study Group
    N Engl J Med; 1981 Apr; 304(14):801-7. PubMed ID: 7010157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral captopril versus placebo among 14,962 patients with suspected acute myocardial infarction: a multicenter, randomized, double-blind, placebo controlled clinical trial. Chinese Cardiac Study (CCS-1) Collaborative Group.
    Chin Med J (Engl); 1997 Nov; 110(11):834-8. PubMed ID: 9772413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Beta-blockade with timolol after myocardial infarction (author's transl)].
    Meister W
    MMW Munch Med Wochenschr; 1981 Sep; 123(38):1403-6. PubMed ID: 6793858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 48-h intravenous trimetazidine on short- and long-term outcomes of patients with acute myocardial infarction, with and without thrombolytic therapy; A double-blind, placebo-controlled, randomized trial. The EMIP-FR Group. European Myocardial Infarction Project--Free Radicals.
    Eur Heart J; 2000 Sep; 21(18):1537-46. PubMed ID: 10973768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term mortality in patients with myocardial infarction: impact of early treatment with captopril for 4 weeks.
    Liu L;
    Chin Med J (Engl); 2001 Feb; 114(2):115-8. PubMed ID: 11780187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma.
    Mastropasqua L; Carpineto P; Ciancaglini M; Gallenga PE
    Ophthalmology; 1999 Mar; 106(3):550-5. PubMed ID: 10080213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Göteborg metoprolol trial. Effects on mortality and morbidity in acute myocardial infarction.
    Hjalmarson A; Herlitz J; Holmberg S; Rydén L; Swedberg K; Vedin A; Waagstein F; Waldenström A; Waldenström J; Wedel H; Wilhelmsen L; Wilhelmsson C
    Circulation; 1983 Jun; 67(6 Pt 2):I26-32. PubMed ID: 6342837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group.
    Breddin K; Loew D; Lechner K; Oberla K; Walter E
    Circulation; 1980 Dec; 62(6 Pt 2):V63-72. PubMed ID: 6777073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Lopressor Intervention Trial: multicentre study of metoprolol in survivors of acute myocardial infarction. Lopressor Intervention Trial Research Group.
    Eur Heart J; 1987 Oct; 8(10):1056-64. PubMed ID: 2890522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study.
    Ferrari R;
    Arch Intern Med; 2006 Mar; 166(6):659-66. PubMed ID: 16567606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta blockade after myocardial infarction: the Norwegian propranolol study in high-risk patients.
    Hansteen V
    Circulation; 1983 Jun; 67(6 Pt 2):I57-60. PubMed ID: 6342841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.